Insperity (NSP) is back in focus after the human resources specialist stepped into the spotlight as a presenting sponsor of the 2026 Inc. 5000 Conference, emphasizing artificial intelligence driven HR tools.
That AI spotlight lands on a stock that has already logged a strong year to date, with a 27.91% share price return and a recent 7 day gain of 6.42% pointing to building momentum even as the 3 year total shareholder return is down 44.50%.
Scan beyond Insperity and find other HR and AI focused businesses on our hand picked 39 profitable AI stocks that aren't just burning cash.
Insperity now trades only modestly below analyst targets, yet at a heavy discount to some fair value estimates after a sharp rebound. Is the market correctly pricing in caution after multi year losses, or misreading the reset?
Most Popular Narrative: 4.5% Undervalued
On the latest figures, Insperity closed at $49.40 against a widely followed fair value marker of $51.75. As a result, the current narrative leans toward a modest discount while hinging heavily on margin repair and mid market traction actually materialising.
The margin recovery plan that includes client repricing, benefit plan redesign and the updated UnitedHealthcare contract, which management expects to reduce gross benefits costs by about 2% and has already coincided with benefit cost per covered employee rising around 5% year over year instead of around 9%, continues to target higher gross profit and stronger net margins.
See why 6 investors see Insperity as 5% undervalued.
Result: Fair Value of $51.75 (UNDERVALUED)
Still, the Insperity story can break if healthcare costs outpace repricing efforts or if HRScale and AI tools fail to gain broader mid market adoption.
Find out about the key risks to this Insperity narrative.
Next Steps
Mixed signals around Insperity can either feel like noise or a useful tension that sharpens your thinking, so move fast, review the data, and weigh both the 3 key rewards and 1 important warning sign.
Looking for more investment ideas beyond Insperity?
Do not stop with Insperity. Use the Simply Wall Street Screener to pressure test your next moves and quickly spot opportunities that might fit your style.
- Target potential mispricing by scanning for quality stocks that still trade at a discount through the 32 high quality undervalued stocks.
- Strengthen your income stream by reviewing companies built around robust payouts with the 8 dividend fortresses.
- Protect your downside by filtering for resilient businesses using the 32 resilient stocks with low risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com